Business Context and Reporting Period
Aimei Health Technology Co., Ltd. (AFJK), a Cayman Islands emerging growth company, filed this Form 8-K on March 4, 2026. The filing reports the extension of the company's deadline to consummate an initial business combination.
Key Financial Metrics
- Extension Payment: $34,330.96 deposited into the trust account.
- Debt Obligation: $34,330.96 unsecured promissory note issued to the Sponsor (Aimei Health Ltd) and United Hydrogen Group Inc.
- Interest Rate: 0% (non-interest bearing).
- Conversion Option: Note may be converted into private units at $10.00 per unit.
- Liquidity Impact: Funds were contributed equally by the Sponsor and United Hydrogen ($17,165.48 each) to fund the extension.
Material Changes
The company extended its termination date for consummating a business combination from March 6, 2026, to April 6, 2026. This represents the sixteenth extension permitted under the company's Amended and Restated Articles of Association. The extension was funded by the issuance of the promissory note described above.
Outlook, Risks, and Contingencies
The promissory note becomes due and payable upon the consummation of the business combination with United Hydrogen Group Inc. If the combination is not consummated, the note's repayment terms are not explicitly detailed in this summary beyond the due date trigger. The payees retain the right, but not the obligation, to convert the debt into equity prior to closing. The filing does not provide specific revenue, profit, or cash flow metrics for the period.
Investor Verification Checklist
- Verify the total number of outstanding public shares to confirm the $0.033 per share extension calculation.
- Review the full text of the Promissory Note (Exhibit 10.1) for specific default or repayment terms if the business combination fails.
- Confirm the status of the proposed business combination with United Hydrogen Group Inc.
- Check the trust account balance to ensure the $34,330.96 deposit was successfully credited.